Rethinking prophylactic central neck dissection in clinically node-negative papillary thyroid cancer

Area of Science:

• Oncology
• Surgical Oncology
• Head and Neck Surgery

Background:

• Papillary thyroid cancer frequently presents with lymph node metastases, often in the central compartment.
• These metastases are typically undetected preoperatively (cN0) and found during dissection.
• The necessity of prophylactic central neck dissection (pCND) is debated due to low recurrence rates without it and potential morbidity.

Purpose of the Study:

• To summarize the current evidence and controversy surrounding prophylactic central neck dissection in papillary thyroid cancer.
• To explore the challenges in conducting randomized trials for surgical procedures like pCND.
• To propose future research directions to resolve the ongoing debate.

Main Methods:

• Review of existing clinical data and studies on prophylactic central neck dissection.
• Analysis of survival rates, regional recurrence rates, and associated morbidity (e.g., temporary hypoparathyroidism).
• Discussion of current guideline recommendations and clinical decision-making processes.

Main Results:

• Clinical data do not demonstrate a survival advantage with prophylactic central neck dissection.
• Some studies suggest a reduction in regional recurrence rates but with an increase in morbidity.
• Recurrence in clinically detected lymph nodes occurs in fewer than 10% of patients even without prophylactic dissection.

Conclusions:

• The decision for prophylactic central neck dissection remains complex and individualized.
• Further research, potentially novel trial designs, is needed to definitively establish the role of pCND.
• Balancing recurrence reduction against surgical morbidity is key in managing papillary thyroid cancer lymph node metastases.